Navigation Links
Ansell Extends Antimicrobial Product Offering with New Non-latex Surgical Glove
Date:11/26/2012

ISELIN, New Jersey, November 26, 2012 /PRNewswire/ --

Ansell, a global leader in protection solutions, today announced the extension of its market-leading antimicrobial technology product range, to include non-latex surgical gloves. The advanced GAMMEX® Non-Latex Antimicrobial[1],[3] surgical glove is now available in Canada, with broader roll-out to follow.

Ansell first launched its unique and proprietary AMT™ Antimicrobial Technology, to industry acclaim, in Australia in 2010, with the GAMMEX Powder-Free with AMT Antimicrobial Technology surgical glove. Today, Ansell is building on this success and extending its antimicrobial technology range to include a latex-free surgical glove, another new to the world medical device.

The GAMMEX Non-Latex Antimicrobial surgical glove provides a new level of protection for healthcare workers, protecting not only against latex (Type I) allergies, but against microbial transmission due to intraoperative glove breaches. Up to 83% of glove breaches go unnoticed by surgeons, further increasing the risk of contamination.*

The glove's antimicrobial chlorhexidine gluconate (CHG) coating is effective against 99% of the Hepatitis C virus, HIV-1 strain Mn and six common infectious bacteria, including drug-resistant MRSA[2].

"The GAMMEX Non-Latex Antimicrobial surgical glove is another indication of our commitment to develop clinically relevant products in anticipation of healthcare workers' needs," said Anthony B. Lopez, President and General Business Manager, Ansell Medical Solutions. "Our relentless focus on innovation is evident in the new products and technologies we launch aimed at providing the utmost protection for healthcare workers and patients alike."

The GAMMEX brand is the global brand leader in surgical gloves, with more than 100 million pairs used annually in hospitals worldwide. The GAMMEX product range incorporates cutting-edge technologies to provide a wide range of advanced protection solutions for healthcare professionals. Today, Ansell takes this protection to a new level and sets a new standard for infection prevention in the global healthcare industry.

* Thomas S. Agarwal M. Mehta G. Intraoperative glove perforation-single versus double gloving in protection against skin contamination. Postgrad Med J. 2001;77:458-460.

[1] GAMMEX® Non-Latex Antimicrobial gloves are not proven to protect against blood-borne infections where the skin is broken, cut or punctured.

[2] Kill rates were achieved following five minutes of exposure.

[3] The GAMMEX® Non-Latex Antimicrobial surgical glove is an investigational device not available for sale outside of Canada.

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well being. With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs more than 10,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well being category worldwide. Ansell operates in four main business segments: Medical Solutions, Industrial Solutions, Specialty Markets and Sexual Wellness.

Information on Ansell and its products can be found at http://www.ansell.com  

Ansell Protected, HyFlex, GAMMEX, SKYN and ACTIVARMR are trademarks owned by Ansell Limited or one of its affiliates.

® and ™ are owned by Ansell Limited or one of its affiliates.

© 2012 Ansell Limited. All rights reserved.


'/>"/>
SOURCE Ansell Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ansell Limited and Ramsay Health Care Enter Global Multi-Year Purchasing Agreement
2. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
3. In Observance of Veterans Day Reproductive Medicine Associates of New Jersey Extends "Helping Heroes Build Families" Program
4. National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production
5. ConvaTec, A Leader In Antimicrobial Dressings And Infection Management, To Host Live International Webcast On Minimizing Risk Of Wound Infections
6. Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
9. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
10. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
11. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):